+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AB Science - logo

AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.

From
From
Masitinib Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Masitinib Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Skin Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Skin Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
From
Metastatic Liver Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Liver Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Alzheimer's Disease Therapeutics Market 2024-2028 - Product Thumbnail Image

Alzheimer's Disease Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 168 Pages
  • Global
From
From
From
Alzheimer's Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Alzheimer's Disease Treatment Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Alzheimer's Disease - Pipeline Insights, 2024 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Insights, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Loading Indicator